drugset
drugset / Trial / NCT07064278

Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children

NCT07064278 ↗

Completed 260 enrolled Children's Hospital of Hebei Province
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates whether a combined approach using bronchoscopy, chest CT scoring, and monocyte subpopulation analysis can improve clinical outcomes for children with refractory Mycoplasma pneumoniae pneumonia (RMPP) when compared to conventional treatment. The goal is to determine if this multi-dimensional assessment can lead to more personalized and effective treatment, resulting in shorter recovery times, lower recurrence rates, and better quality of life.

Timeline

Start
2022-12-01
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 4 mg/kg —
Subject Prednisone Other / unclassified 1 mg/kg Oral
Background Azithromycin Small molecule 10 mg/kg Intravenous

Indications

Mycoplasma pneumoniae pneumonia